ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.287 | -10.801656003 | 2.657 | 2.657 | 2.18 | 357162 | 2.30305456 | CS |
4 | -0.14 | -5.57768924303 | 2.51 | 2.83 | 2.18 | 313706 | 2.54440804 | CS |
12 | -1.12 | -32.0916905444 | 3.49 | 4.21 | 2.18 | 526670 | 3.24260129 | CS |
26 | 0.49 | 26.0638297872 | 1.88 | 4.62 | 1.65 | 845510 | 3.65703156 | CS |
52 | -0.11 | -4.43548387097 | 2.48 | 4.62 | 1.61 | 526711 | 3.37026607 | CS |
156 | -4.35 | -64.7321428571 | 6.72 | 6.79 | 0.53 | 831817 | 2.26883412 | CS |
260 | -6.01 | -71.7183770883 | 8.38 | 9.46 | 0.53 | 804288 | 4.24747958 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales